← All diseases Cancer

Lung cancer (small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (174)Meta-analysis (63)Treatment guideline (1)Randomized trial (47)Systematic review (37)Phase 3 study (26)Clinical trial (664)Review article (254)Early study (phase 1 or 2) (69)Case report (159)Laboratory or animal research (71)Commentary or Editorial (81)Retracted publication (17) Studies currently seeking participants only (63)

Filter

Publications and studies (3302)

• Probing Folate-Responsive and Stage-Sensitive Metabolomics and Transcriptional Co-Expression Network Markers to Predict Prognosis of Non-Small Cell Lung Cancer Patients. (2022/12/20) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs. (2022/12/16) ♡
• Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer. (2022/12/14) ♡
• Silibinin Overcomes EMT-driven Lung Cancer Resistance to New-Generation ALK Inhibitors. (2022/12/11) ♡
• Highly sensitive noninvasive early lung cancer detection using DNA methylation topology in sputum-derived epithelial cells. (2022/12/10) ♡
• Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TopMed program. (2022/12/08) ♡
• Association of travel distance, surgical volume, and receipt of adjuvant chemotherapy with survival among patients with resectable lung cancer. (2022/12/08) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. PD-L1 blockade by immune checkpoint inhibitors impairs sensitivity to osimertinib in EGFR mutant non-small cell lung cancer cells. (2022/12/07) ♡
• Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation. (2022/12/05) ♡
• Association of Pretreatment Physical and Geriatric Parameters with Treatment Tolerance and Survival in Elderly Patients with Stage I-II Non-Small Cell Lung Cancer: An Evaluation of Usual Care Data. (2022/12/05) ♡
• Expression of PD-L1 in Lung Carcinoma and Its Correlation with Histopathological Grade, Stage, and Survival of Patients (2022/12/05) ♡
• Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes. (2022/12/02) ♡
• Changes in Body Weight, Body Composition, Phase Angle, and Resting Metabolic Rate in Male Patients with Stage IV Non-Small-Cell Lung Cancer Undergoing Therapy. (2022/12/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of hepatitis induced by herbal medicine in non-small cell lung cancer patient treated by a combination of immunotherapy and chemotherapy. (2022/12/01) ♡
• IRE1α-XBP1 regulates PDK1-dependent induction of epithelial-mesenchymal transition in non-small cell lung cancer cells. (2022/12/01) ♡
• Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking. (2022/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Aqueous Extract of Artemisia annua Shows In Vitro Antimicrobial Activity and an In Vivo Chemopreventive Effect in a Small-Cell Lung Cancer Model. (2022/12/01) ♡
• Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. (2022/12/01) ♡
• Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming. (2022/12/01) ♡
• Comparative study of TNF-α and vitamin D reveals a significant role of TNF-α in NSCLC in an ethnically conserved vitamin D deficient population. (2022/12/01) ♡
• Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H. (2022/12/01) ♡
• Intraoperative ultrasound: "Alternative eye" in lymph nodal dissection in non-small cell lung cancer. (2022/12/01) ♡
• AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models. (2022/12/01) ♡
• Chromium (VI)-induced ALDH1A1/EGF axis promotes lung cancer progression. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy? (2022/12/01) ♡
• Transcriptome of Lung Cancer Cells Resistant to the Cytotoxic Activity of Macrophages. (2022/12/01) ♡
• Computed tomography-guided iodine-125 radioactive seed implantation in small-cell lung cancer: A retrospective study. (2022/12/01) ♡
• Serum circulating free DNA of syncytin-1 as a novel molecular marker for early diagnosis of non-small-cell lung cancer. (2022/12/01) ♡
• Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer. (2022/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Combi-TED: a new trial testing Tedopi(®) with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line. (2022/12/01) ♡
• Low level of complement factor H increases the risk of cancer-related death in patients with small-cell lung cancer. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion. (2022/12/01) ♡
• The role and mechanisms of long non-coding RNA LINC00662 in promoting the proliferation, migration, and angiogenesis of BGC-823 and HGC-27 cells and the subsequent effect on the progression of gastric cancer. (2022/12/01) ♡
• Histopathological characterization of lung tumours at the University Teaching Hospital, Lusaka, Zambia: a pilot study. (2022/12/01) ♡
• Investigation of the effects of mir-219-1 gene variants on the development of disease in non-small cell lung cancer patients. (2022/12/01) ♡
• TLR4 Blockade Using Docosahexaenoic Acid Restores Vulnerability of Drug-Tolerant Tumor Cells and Prevents Breast Cancer Metastasis and Postsurgical Relapse. (2022/12/01) ♡
• Elucidation of the inhibitory potential of flavonoids against PKP1 protein in non-small cell lung cancer. (2022/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pseudo Primary Aldosteronism as Initial Presentation of Ectopic ACTH Syndrome in Metastatic Small Cell Lung Cancer. (2022/11/30) ♡
• 1-year mortality in lung cancer in France according to key timepoints of care pathways. (2022/11/28) ♡
• Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab. (2022/11/28) ♡
• Pancerebellitis Under Immunotherapy With Pembrolizumab. (2022/11/25) ♡
• Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy. (2022/11/24) ♡
• Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation. (2022/11/24) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling. (2022/11/24) ♡
• Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy. (2022/11/23) ♡
• Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy. (2022/11/22) ♡
• Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry. (2022/11/20) ♡
• An exercise prescription for patients with lung cancer improves the quality of life, depression, and anxiety. (2022/11/17) ♡
• Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients. (2022/11/17) ♡
• Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF. (2022/11/15) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.